Anil TM, Dandu A, Harsha K, Singh J, Shree N, Kumar VS, Lakshmi MN, Sunil V, Harish C, Balamurali GV, Naveen Kumar BS, Gopala AS, Pratibha S, Sadasivuni M, Anup MO, Moolemath Y, Venkataranganna MV, Jagannath MR, Somesh BP (2014) A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits. BMC Pharmacol Toxicol 15:43
Article
Google Scholar
Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Toz H, Berdeli A, Atilla G, McKay IJ, Hughes FJ, Belibasakis GN (2007) Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 42:287–293
Article
Google Scholar
Breivik T, Opstad PK, Gjermo P, Thrane PS (2000) Effects of hypothalamic–pituitary–adrenal axis reactivity on periodontal tissue destruction in rats. Eur J Oral Sci 108:115–122
Article
Google Scholar
Breivik T, Thrane PS, Gjermo P, Opstad PK, Pabst R, von Horsten S (2001) Hypothalamic–pituitary–adrenal axis activation by experimental periodontal disease in rats. J Periodontal Res 36:295–300
Article
Google Scholar
Bujalska IJ, Kumar S, Stewart PM (1997) Does central obesity reflect “Cushing’s disease of the omentum”? Lancet 349:1210–1213
Article
Google Scholar
Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR (2013) Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol 137:82–92
Article
Google Scholar
Cirillo N, Hassona Y, Pignatelli M, Gasparoto TH, Morgan DJ, Prime SS (2011) Characterization of a novel oral glucocorticoid system and its possible role in disease. J Dent Res 91:97–103
Article
Google Scholar
D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, Tsakos G (2008) Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 93:3989–3994
Article
Google Scholar
Feig PU, Shah S, Hermanowski-Vosatka A, Plotkin D, Springer MS, Donahue S, Thach C, Klein EJ, Lai E, Kaufman KD (2011) Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome. Diabetes Obes Metab 13:498–504
Article
Google Scholar
Genco RJ, Ho AW, Kopman J, Grossi SG, Dunford RG, Tedesco LA (1998) Models to evaluate the role of stress in periodontal disease. Ann Periodontol 3:288–302
Article
Google Scholar
Gross KL, Cidlowski JA (2008) Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol Metab 19:331–339
Article
Google Scholar
Hamilton BS, Himmelsbach F, Nar H, Schuler-Metz A, Krosky P, Guo J, Guo R, Meng S, Zhao Y, Lala DS, Zhuang L, Claremon DA, McGeehan GM (2015) Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes. Eur J Pharmacol 746:50–55
Article
Google Scholar
Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM, Gittoes NJ, Buckley CD, Raza K, Cooper MS (2008) Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis 67:1204–1210
Article
Google Scholar
Haririan H, Bertl K, Laky M, Rausch WD, Bottcher M, Matejka M, Andrukhov O, Rausch-Fan X (2012) Salivary and serum chromogranin A and α-amylase in periodontal health and disease. J Periodontol 83:1314–1321
Article
Google Scholar
Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, Noonan H, Nunes CN, Olson SH, Pikounis B, Ren N, Robertson N, Schaeffer JM, Shah K, Springer MS, Strack AM, Strowski M, Wu K, Wu T, Xiao J, Zhang BB, Wright SD, Thieringer R (2005) 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202:517–527
Article
Google Scholar
Hilgert JB, Hugo FN, Bandeira DR, Bozzetti MC (2006) Stress, cortisol, and periodontitis in a population aged 50 years and over. J Dent Res 85:324–328
Article
Google Scholar
Ishisaka A, Ansai T, Soh I, Inenaga K, Yoshida A, Shigeyama C, Awano S, Hamasaki T, Sonoki K, Takata Y, Takehara T (2007) Association of salivary levels of cortisol and dehydroepiandrosterone with periodontitis in older Japanese adults. J Periodontol 78:1767–1773
Article
Google Scholar
Ishisaka A, Ansai T, Soh I, Inenaga K, Awano S, Yoshida A, Hamasaki T, Sonoki K, Takata Y, Nishihara T, Takehara T (2008) Association of cortisol and dehydroepiandrosterone sulphate levels in serum with periodontal status in older Japanese adults. J Clin Periodontol 35:853–861
Article
Google Scholar
Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ (1997) 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94:14924–14929
Article
Google Scholar
Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, Walker BR (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560–563
Google Scholar
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166–2170
Article
Google Scholar
Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS (2003) Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83–90
Article
Google Scholar
Mengel R, Bacher M, Flores-De-Jacoby L (2002) Interactions between stress, interleukin-1β, interleukin-6 and cortisol in periodontally diseased patients. J Clin Periodontol 29:1012–1022
Article
Google Scholar
Mesa F, Magan-Fernandez A, Munoz R, Papay-Ramirez L, Poyatos R, Sanchez-Fernandez E, Galindo-Moreno P, Rodriguez-Barranco M (2014) Catecholamine metabolites in urine, as chronic stress biomarkers, are associated with higher risk of chronic periodontitis in adults. J Periodontol 85:1755–1762
Article
Google Scholar
Morita T, Yamazaki Y, Mita A, Takada K, Seto M, Nishinoue N, Sasaki Y, Motohashi M, Maeno M (2010) A cohort study on the association between periodontal disease and the development of metabolic syndrome. J Periodontol 81:512–519
Article
Google Scholar
Nuotio-Antar AM, Hachey DL, Hasty AH (2007) Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab 293:E1517–E1528
Article
Google Scholar
Okazaki S, Takahashi T, Iwamura T, Nakaki J, Sekiya Y, Yagi M, Kumagai H, Sato M, Sakami S, Nitta A, Kawai K, Kainoh M (2014) HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models. J Pharmacol Exp Ther 351:181–189
Article
Google Scholar
Paulsen SK, Pedersen SB, Fisker S, Richelsen B (2007) 11β-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity 15:1954–1960
Article
Google Scholar
Rai B, Kaur J, Anand SC, Jacobs R (2011) Salivary stress markers, stress, and periodontitis: a pilot study. J Periodontol 82:287–292
Article
Google Scholar
Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418–1421
Article
Google Scholar
Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med 353:1711–1723
Article
Google Scholar
Rosania AE, Low KG, McCormick CM, Rosania DA (2009) Stress, depression, cortisol, and periodontal disease. J Periodontol 80:260–266
Article
Google Scholar
Rosenstock J, Banarer S, Fonseca VA, Inzucchi SE, Sun W, Yao W, Hollis G, Flores R, Levy R, Williams WV, Seckl JR, Huber R (2010) The 11-β-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care 33:1516–1522
Article
Google Scholar
Saito T, Shimazaki Y, Sakamoto M (1998) Obesity and periodontitis. N Engl J Med 339:482–483
Article
Google Scholar
Seckl JR, Walker BR (2001) Minireview: 11β-hydroxysteroid dehydrogenase type 1—a tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371–1376
Google Scholar
Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y (2007) Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J Dent Res 86:271–275
Article
Google Scholar
Shiraishi M, Sawai H, Nagano Y, Ueda M, Umeda M (2013) Involvement of 11β-HSD1 in metabolic syndrome and periodontal disease. J Osaka Dent Univ 47:7–10
Google Scholar
Stegk JP, Ebert B, Martin HJ, Maser E (2009) Expression profiles of human 11β-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases. Mol Cell Endocrinol 301:104–108
Article
Google Scholar
Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM (2004) 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831–866
Article
Google Scholar
Vernal R, Dutzan N, Hernandez M, Chandia S, Puente J, Leon R, Garcia L, Del Valle I, Silva A, Gamonal J (2006) High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes. J Periodontol 77:1772–1780
Article
Google Scholar
Wara-aswapati N, Surarit R, Chayasadom A, Boch JA, Pitiphat W (2007) RANKL upregulation associated with periodontitis and Porphyromonas gingivalis. J Periodontol 78:1062–1069
Article
Google Scholar
Zbankova S, Bryndova J, Leden P, Kment M, Svec A, Pacha J (2007) 11β-hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis. J Gastroenterol Hepatol 22:1019–1023
Article
Google Scholar